Skip to content
The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

  • Sponsor Login
  • Newsletter Sign-up

  • About Us
        • The MRCT Center
        • How We Work
        • Our Focus Areas
        • Meet the MRCT Center Team
        • External Advisory Board
        • Get Involved
        • Funding & Support
        • Annual Reports
        • Our Sponsors / Become a Sponsor
  • Our Work
        • Clinical Trials & Research
          • Cell and Gene Therapies
          • Artificial Intelligence (AI) and Clinical Research
          • Environmental Sustainability in Clinical Trials
          • From Policy to Practice: Implementing the EHDS for Responsible Data Sharing
          • Health Literacy in Clinical Research
          • Oversight and Implementation of Decentralized Elements in Clinical Trials
          • Post-Trial Responsibilities
          • Promoting Global Clinical Research in Children
          • Protocol Ethics Toolkit and E-Learning
          • Real World Evidence
          • Representation in Research
          • Reproductive Health Considerations in Clinical Research
          • Return of Aggregate Results
          • Return of Individual Results
        • For Patients & Participants
        • Quality & Transparency
          • Advancing the Quality of Clinical Trial Enterprise
          • Data Sharing
          • Impact of Privacy Laws on Clinical Research
          • Policy Engagement
          • Proactive Safety Surveillance: A Global Approach
        • Capacity Building
          • Global Regulatory Engagement
          • Joint Task Force for Clinical Trial Competency
          • Research Ethics Committee Systems Optimization
          • Training & Education
        • Clinical Research Glossary
        • Bioethics Collaborative
        • Research, Development, & Regulatory Roundtable (R3)
        • Project-Specific Websites
          • Health Literacy in Clinical Research
          • Joint Task Force for Clinical Trial Competency
          • Return of Individual Results
        • See All Our Work
  • News & Events
        • News
          • All News
          • Publications by the MRCT Center
          • MRCT Center Newsletter
        • Upcoming Events
          • Upcoming Events
          • Past Events & Assets
  • Resources
  • Contact

Resource Type: Public Comments

MRCT Center submits comments to National Institutes of Health (NIH) on Developing Consent Language for Future Use of Data and Biospecimens

Public Comments

Comments provided on: September 28, 2021

Comments provided to: National Institutes of Health, Bethesda, Maryland

View PDF
Download File Here

Comments related to 2005 PHS Policies on Research Misconduct

Public Comments

Comments provided on: October 31, 2022

Comments provide to: Office of Research Integrity, Department of Health and Human Services

View Document

Comments to European Data Protection Board Guidelines 04/2021 on Codes of Conduct as Tools for Transfers

Public Comments

Comments provided on: September 28, 2021

Comments provided to: European Data Protection Board

View PDF

EDPB Stakeholder event on the application of the GDPR to the processing of personal data for scientific research purposes

Publication

Comments provided on: April 30, 2021

Comments provided to: European Data Protection Board (EDPB)

View PDF
Download PDF Here

Response to the FDA’s RFI on Rare Disease Clinical Trial Networks, supporting the Rare Disease Cures Accelerator

Public Comments

Comments provided on: July 20, 2020

Comments provided to: Food and Drug Administration (FDA)

View PDF
Download PDF Here

Response to FDA’s request for comments on strategic priorities for the Office of Minority Health and Health Equity (OMHHE)

Public Comments

Comments provided on: June 29, 2020

Comments provided to: Food and Drug Administration (FDA)

View Public Comments
FDA-2019-N-4824-0062_attachment_1

Response to European Commission’s request for feedback regarding the General Data Protection Regulation (GDPR)

Public Comments

Comments provided on: April 29, 2020

Comments provided to : European Commission

View Comments

Comments to EDPB on the Guidelines on the Territorial Scope of the GDPR

Public Comments

Comments provided on: January 18, 2019

Comments provided to: European Data Protection Board

View Comments

Regulation of New Drugs and Clinical Trials Rules: Comments and Recommendations

Public Comments

Comments provided on: March 16, 2018

Comments provided to: Ministry of Health and Family Welfare, New Delhi, India

View PDF
Download File Here

NIH and FDA Draft Clinical Trial Protocol Template for Phase 2 and 3 IND/IDE Studies

Public Comments

Comments Provided on: April 15, 2016

Comments Provided to: The International Committee of Medical Journal Editors

View PDF
Download File Here

Posts navigation

Older posts
Newer posts

The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard

75 Francis Street, TH‐14‐1403, Boston, MA 02115, USA

mrct@bwh.harvard.edu

Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution 4.0 International license.

  • About the MRCT Center
  • Our Work
  • News
  • Upcoming Events
  • Resources
  • Sponsors
  • Contact Us

Sign Up for Our Newsletter

Copyright © 2026 Brigham and Women’s Hospital Division of Global Health Equity

Privacy and Terms of Use

website by: bartlett